Literature DB >> 1294521

Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/co-trimoxazole.

K G Naber1, U Thyroff-Friesinger.   

Abstract

In a multicentric study comparing oral single-dose therapy of fosfomycin trometamol (3 g as fosfomycin) versus co-trimoxazole (1.92 g) or ofloxacin (200 mg) as many as possible of the pathogens were sent to and analysed in a central laboratory. The pathogens were identified and minimal inhibitory concentrations (MIC) of fosfomycin, trimethoprim alone and in combination with sulfamethoxazole, ofloxacin, ampicillin, amoxicillin combined with clavulanic acid, and cephadroxil were determined. The eradication of pathogens (cfu < 10(3)/ml at one week after single-dose therapy) was analysed according to species and MIC of the antibiotic used. Urine cultures of 349 patients were analysed. Escherichia coli was the predominating species followed by staphylococci and Proteus mirabilis. Enterococci were mostly found in mixed culture. Baseline pathogens of monoinfections were eradicated in 87.1%, in 88.9% and in 86.4% of 284 patients treated with fosfomycin trometamol, co-trimoxazole and ofloxacin, respectively. The MICs of the five antibacterial agents and the two antibiotic combinations for 253 baseline pathogens showed that of the E. coli strains none was resistant to ofloxacin, three (MIC = 128 mg/l) were resistant to fosfomycin, 3.6% to co-trimoxazole, 6.2% to trimethoprim, 8.8% to ampicillin, and 5.7% to amoxicillin/clavulanic acid. The eradication rates according to the MICs of the corresponding drugs showed equally good eradication rates for fosfomycin up to an MIC of 64 mg/l. Above this level two out of three strains were also eradicated by fosfomycin trometamol. For co-trimoxazole and ofloxacin no intermediately sensitive or resistant strains were found. Within the range of MICs found there were equally good eradication rates for both antibacterial agents.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1294521     DOI: 10.1007/bf01710018

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. The Inter-Nordic Urinary Tract Infection Study Group.

Authors: 
Journal:  Scand J Infect Dis       Date:  1988

Review 2.  Review of norfloxacin in lower urinary tract infections.

Authors:  L Miano; S Goldoni; A Tubaro; G Paradiso Galatioto; P Gandolfi
Journal:  Eur Urol       Date:  1990       Impact factor: 20.096

Review 3.  Short-term treatment of uncomplicated lower urinary tract infections in women.

Authors:  S R Norrby
Journal:  Rev Infect Dis       Date:  1990 May-Jun

4.  Single-dose treatment of acute urinary tract infection: a controlled trial.

Authors:  R N Grüneberg; W Brumfitt
Journal:  Br Med J       Date:  1967-09-09

5.  The trometamol salt of fosfomycin: microbiological evaluation.

Authors:  D Greenwood; S Coyle; J Andrew
Journal:  Eur Urol       Date:  1987       Impact factor: 20.096

6.  Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study.

Authors:  K G Naber; U Thyroff-Friesinger
Journal:  Infection       Date:  1990       Impact factor: 3.553

Review 7.  Review of published studies on single dose therapy of urinary tract infections.

Authors:  R R Bailey
Journal:  Infection       Date:  1990       Impact factor: 3.553

8.  Trometamol-fosfomycin (Monuril) bioavailability and food-drug interaction.

Authors:  E Bergogne-Bérézin; C Muller-Serieys; M L Joly-Guillou; N Dronne
Journal:  Eur Urol       Date:  1987       Impact factor: 20.096

9.  Trimethoprim resistance and trimethoprim usage in and around The Royal Free Hospital in 1985.

Authors:  J M Hamilton-Miller; D Purves
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

  9 in total
  2 in total

Review 1.  Ofloxacin. A reappraisal of its use in the management of genitourinary tract infections.

Authors:  S V Onrust; H M Lamb; J A Balfour
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

2.  Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients.

Authors:  R Janknegt; P M Hooymans; G T Fabius; M K Nohlmans-Paulssen; C Machielsen; J Boogaard-van den Born; J Rang; C A Smits; M E Willems-Thissen; A Krommenhoek
Journal:  Pharm World Sci       Date:  1994-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.